BiotechTube
Home/Amneal Pharmaceuticals/Srinivas Kone, PhD
SK

Srinivas Kone, PhD

Senior Vice President, Chief Scientific Officer – Generics

Amneal Pharmaceuticals

Therapeutic Areas

OncologyCentral Nervous SystemGastroenterologyEmergency/Critical CareHematologyOphthalmologyPsychiatry

Amneal Pharmaceuticals Pipeline

DrugIndicationPhase
Mesalamine DR (Asacol® HD)Gastroenterology (Ulcerative Colitis)ANDA Approved
Everolimus (Afinitor®)OncologyANDA Approved
Epinephrine (Adrenalin®)Emergency/Critical CareANDA Pending
Prednisolone acetate (Pred-Forte®)OphthalmologyANDA Pending
Risperidone ER (Risperdal Consta®)PsychiatryANDA Pending
Iohexol (Omnipaque®)Diagnostic ImagingANDA Pending
Eltrombopag (Promacta®)HematologyANDA Pending

Leadership Team at Amneal Pharmaceuticals

CP
Chirag Patel
President and Co-Chief Executive Officer
CP
Chintu Patel
Co-Chief Executive Officer
TK
Tasos Konidaris
Executive Vice President, Chief Financial Officer
AS
Andrew S. Boyer
Executive Vice President, Chief Commercial Officer – Generics & Biosciences
JR
Joe Renda
Senior Vice President, Chief Commercial Officer - Specialty
MW
Maryll W. Toufanian
Senior Vice President, Regulatory Strategy and Government Affairs
PM
Paul Meister
Chairman of the Board
View full Amneal Pharmaceuticals profile